Skip to main content

Table 2 Seropositivity and estimated serological conversion rate (eSCR) for PfMSP-119, CSP, and LSA-1 antibodies

From: Analysis of anti-Plasmodium IgG profiles among Fulani nomadic pastoralists in northern Senegal to assess malaria exposure

 DaganaKanelPetePodorRanerou
PfMSP-119
 Seropositivity % (95% CI)37.9 (32.3–43.7)63.4 (57.6–68.9)55.8 (49.9–61.6)28.0 (23.0–33.5)39.9 (34.3–45.8)
 eSCR0.022 (0.008–0.04)0.063 (0.04–0.08)0.047 (0.03–0.06)0.015 (0.008–0.02)0.029 (0.02–0.04)
CSP
 Seropositivity % (95% CI)9.9 (6.7–13.9)14.6 (10.8–19.1)20.4 (16.0–25.5)10.1 (6.9–14.2)5.1 (2.9–8.3)
 eSCR0.0040 (0.004–0.008)0.0055 (0.002–0.009)0.0093 (0.002–0.02)0.0045 (0.0004–0.008)0.0026 (0.006–0.01)
LSA-1
 Seropositivity % (95% CI)3.8 (1.9–6.6)6.4 (3.9–9.9)8.8 (5.9–12.7)2.7 (1.2–5.3)1.4 (0.4–3.5)
 eSCR0.0015 (0.0004–0.004)0.0014 (0.0004–0.003)0.0035 (0.0004–0.007)0.0064 (0.002–0.01)0.0013 (0.002–0.004)